Achim AIGNER | University of Leipzig, Leipzig | Institute of Pharmacology, Pharmacy and Toxicology | Research profile
Cells | Free Full-Text | MicroRNA-30d-5p—A Potential New Therapeutic Target for Prevention of Ischemic Cardiomyopathy after Myocardial Infarction
Analysis of SATB1 in Head and Neck Squamous Cell Carcinoma
Współpraca międzynarodowa uniwersytetów to większe możliwości
IJMS | Free Full-Text | SATB1-Mediated Upregulation of the Oncogenic Receptor Tyrosine Kinase HER3 Antagonizes MET Inhibition in Gastric Cancer Cells
Achim AIGNER | University of Leipzig, Leipzig | Institute of Pharmacology, Pharmacy and Toxicology | Research profile
Achim AIGNER | University of Leipzig, Leipzig | Institute of Pharmacology, Pharmacy and Toxicology | Research profile
Wissenschaftlicher Mitarbeiter (m/w/d) Klinische Pharmakologie - Universität Leipzig, Medizinische Fakultät - academics
list of registered abstracts (sorted by category) - Universität Leipzig
Module III – CAS in Radiopharmaceutical Chemistry/Radiopharmacy | ETH Zurich
Achim Aigner - AD Scientific Index 2023
Achim AIGNER | University of Leipzig, Leipzig | Institute of Pharmacology, Pharmacy and Toxicology | Research profile
PEI-complexed LNA antiseeds as miRNA inhibitors
Research
Achim AIGNER | University of Leipzig, Leipzig | Institute of Pharmacology, Pharmacy and Toxicology | Research profile
Achim AIGNER | University of Leipzig, Leipzig | Institute of Pharmacology, Pharmacy and Toxicology | Research profile
Contents – CAS in Radiopharmaceutical Chemistry/Radiopharmacy | ETH Zurich
List of registered abstracts - Universität Leipzig
Achim AIGNER | University of Leipzig, Leipzig | Institute of Pharmacology, Pharmacy and Toxicology | Research profile
Universität Leipzig, Jahresbericht 2021
Aktuelles
Exploring the MIR143-UPAR Axis for the Inhibition of Human Prostate Cancer Cells In Vitro and In Vivo: Molecular Therapy - Nucleic Acids
ABOUT US - SiSaf Ltd
Bahiru Goshu - PhD Student - University of Leipzig | LinkedIn
Antibody-Drug Conjugates as a Targeted Therapeutic Approach Across Entities in Oncology (12.05.2023)
